Plus Therapeutics earnings were -$13.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PSTV earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.9M, up 35.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PSTV reported annual earnings of -$13.0M, with -2.5% growth. The next PSTV earnings date is May 13, 2025.
What were Plus Therapeutics's earnings last quarter?
On PSTV's earnings call on Invalid Date, Plus Therapeutics (NASDAQ: PSTV) reported Q4 2024 earnings per share (EPS) of -$0.49, up 30% year over year. Total PSTV earnings for the quarter were -$3.90 million. In the same quarter last year, Plus Therapeutics's earnings per share (EPS) was -$0.70.
The next PSTV earnings date is Invalid Date. Add PSTV to your watchlist to be reminded of Plus Therapeutics's next earnings date.
What was PSTV's earnings growth in the past year?
As of Plus Therapeutics's earnings date in Invalid Date, Plus Therapeutics's earnings has grown year over year. PSTV earnings in the past year totalled -$12.98 million.
Is Plus Therapeutics profitable or losing money?
As of the last Plus Therapeutics earnings report, Plus Therapeutics is currently losing money. Plus Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$12.98 million, a 2.54% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.